All News


Swedish biotech: where's the beef?

Sweden is ranked number one among 31 European nations for its spending on R&D - but it is still looking for its first home-grown biotechnology product.

The brain behind France's new initiatives

Philippe Pouletty is on a roll. One by one, the serial entrepreneur with a penchant for provocative lobbying is seeing his ideas become official French policy. But not everyone is pleased.

Acrongenomics, Imperial's Molecular develop diagnostic devices

Acrongenomics Inc., a Swiss life science venture company and Molecular Vision Ltd., a spin-out from the Imperial College London, said they have signed a memorandum of understanding to jointly develop diagnostic devices for diabetes, drug abuse, STDs and cardiovascular diseases.

Editor's Chair: Fixing European patents

For 30 years, the European Commission has been trying to fix the broken patent process, but keeps running afoul of entrenched intestests. Is it any wonder that European countries keep dropping in the world patent leagues?

Who is in the lead in the knowledge race?

There is much more to a nation's "brain power" than how much it spends on R&D and education. The OECD tries to assess the broader picture by looking at "Investment in knowledge".

Napatech gets $5M from VCs to buy Xyratex's network adapter unit

Napatech, a Danish company that specialised in raising the speed of Internet network appliances, said it has received $5 million from Ferd Venture, Northzone Ventures and existing shareholder DTU Innovation, a fund which is related to the Danish Technical University.

UK budgets for science

The latest budget for the UK continued the Chancellor's role as puppetmaster for science and technology.

What is the point of technology transfer?

Who should benefit from the transfer of technology from the academic world into the business arena? The university that cooked up the ideas, or the company that turned them into money? How about society as a whole? An American Prof warns against micro managing the process.